InvestorsHub Logo
Followers 14
Posts 698
Boards Moderated 0
Alias Born 04/06/2011

Re: john12341 post# 5724

Monday, 12/31/2018 11:52:42 AM

Monday, December 31, 2018 11:52:42 AM

Post# of 6772
Still in process as far as we know. CNab patent is application and use, IMO. Dr Blakeley has neuro and other discoveries / patents also related, Im certainly not a lawyer, but they all seem different IMO...GLTA...

United Cannabis® Corporation has US and worldwide patent protection for its proprietary technology until October 21, 2035. United Cannabis® Corporation’s proprietary cannabinoid compositions are covered by United States Patent No. 9,730,911 (the ‘911 Patent).
The patent covers a variety of liquid formulations containing cannabinoids, with or without certain terpenes/flavonoids, and including formulations infused in a medium chain triglyceride (MCT). The technology can be used with a wide variety of phytotherapeutic products with applications in the medical, pharmaceutical and industrial markets.
United Cannabis® is offering licenses to its ‘911 Patent and related US and worldwide counterparts under terms that are customized to each licensee. Negotiations are
conducted pursuant to mutual non-disclosure agreements. Licensing is available in the United States and all countries where patent protection has been awarded to United Cannabis® via the Patent Cooperation Treaty.
Please contact our General Counsel, Jesús M. Vázquez, at jmv@unitedcannabis.us to

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.